Loading...

UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Emilie Barruet, PhD

Title(s)Associate Specialist, Surgery
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Matsuo K, Chavez RD, Barruet E, Hsiao EC. Inflammation in Fibrodysplasia Ossificans Progressiva and Other Forms of Heterotopic Ossification. Curr Osteoporos Rep. 2019 Dec; 17(6):387-394. PMID: 31721068.
      View in: PubMed
    2. Pennings I, van Dijk LA, van Huuksloot J, Fledderus JO, Schepers K, Braat AK, Hsiao EC, Barruet E, Morales BM, Verhaar MC, Rosenberg AJWP, Gawlitta D. Effect of donor variation on osteogenesis and vasculogenesis in hydrogel cocultures. J Tissue Eng Regen Med. 2019 03; 13(3):433-445. PMID: 30650247.
      View in: PubMed
    3. Barruet E, Morales BM, Cain CJ, Ton AN, Wentworth KL, Chan TV, Moody TA, Haks MC, Ottenhoff TH, Hellman J, Nakamura MC, Hsiao EC. NF-?B/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification. JCI Insight. 2018 11 15; 3(22). PMID: 30429363.
      View in: PubMed
    4. Barruet E, Hsiao EC. Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva. Bone. 2018 04; 109:162-167. PMID: 28716551.
      View in: PubMed
    5. Barruet E, Morales BM, Lwin W, White MP, Theodoris CV, Kim H, Urrutia A, Wong SA, Srivastava D, Hsiao EC. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling. Stem Cell Res Ther. 2016 08 17; 7(1):115. PMID: 27530160.
      View in: PubMed
    6. Cain CJ, Gaborit N, Lwin W, Barruet E, Ho S, Bonnard C, Hamamy H, Shboul M, Reversade B, Kayserili H, Bruneau BG, Hsiao EC. Loss of Iroquois homeobox transcription factors 3 and 5 in osteoblasts disrupts cranial mineralization. Bone Rep. 2016 Dec; 5:86-95. PMID: 27453922.
      View in: PubMed
    7. Barruet E, Hsiao EC. Using Human Induced Pluripotent Stem Cells to Model Skeletal Diseases. Methods Mol Biol. 2016; 1353:101-18. PMID: 25549831.
      View in: PubMed
    8. Badja C, Maleeva G, El-Yazidi C, Barruet E, Lasserre M, Tropel P, Binetruy B, Bregestovski P, Magdinier F. Efficient and cost-effective generation of mature neurons from human induced pluripotent stem cells. Stem Cells Transl Med. 2014 Dec; 3(12):1467-72. PMID: 25355730.
      View in: PubMed
    9. Matsumoto Y, Hayashi Y, Schlieve CR, Ikeya M, Kim H, Nguyen TD, Sami S, Baba S, Barruet E, Nasu A, Asaka I, Otsuka T, Yamanaka S, Conklin BR, Toguchida J, Hsiao EC. Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation. Orphanet J Rare Dis. 2013 Dec 09; 8:190. PMID: 24321451.
      View in: PubMed
    10. Hadjal Y, Hadadeh O, Yazidi CE, Barruet E, Binétruy B. A p38MAPK-p53 cascade regulates mesodermal differentiation and neurogenesis of embryonic stem cells. Cell Death Dis. 2013 Jul 25; 4:e737. PMID: 23887628.
      View in: PubMed
    11. Hadadeh O, Barruet E, Peiretti F, Verdier M, Bernot D, Hadjal Y, Yazidi CE, Robaglia-Schlupp A, De Paula AM, Nègre D, Iacovino M, Kyba M, Alessi MC, Binétruy B. The plasminogen activation system modulates differently adipogenesis and myogenesis of embryonic stem cells. PLoS One. 2012; 7(11):e49065. PMID: 23145071.
      View in: PubMed
    12. Barruet E, Hadadeh O, Peiretti F, Renault VM, Hadjal Y, Bernot D, Tournaire R, Negre D, Juhan-Vague I, Alessi MC, Binétruy B. p38 mitogen activated protein kinase controls two successive-steps during the early mesodermal commitment of embryonic stem cells. Stem Cells Dev. 2011 Jul; 20(7):1233-46. PMID: 20954847.
      View in: PubMed
    13. D. Bernot, E. Barruet, M. Poggi, B. Bonardo, M.C. Alessi, F. Peiretti. PO29 La down-régulation de TIMP-3 est nécessaire à la différenciation adipocytaire. Diabetes & Metabolism. 2010 Mar 1; 36:a35.
      View in: Publisher Site
    14. Bernot D, Barruet E, Poggi M, Bonardo B, Alessi MC, Peiretti F. Down-regulation of tissue inhibitor of metalloproteinase-3 (TIMP-3) expression is necessary for adipocyte differentiation. J Biol Chem. 2010 Feb 26; 285(9):6508-14. PMID: 20056610.
      View in: PubMed
    15. D. Bernot, E. Barruet, M. Poggi, G. Nalbone, M.-C. Alessi, F. Peiretti. B008 Régulation du « système ADAM17 » au cours de la différenciation adipocytaire. Archives of Cardiovascular Diseases. 2009 Mar 1; 102:s23.
      View in: Publisher Site
    16. E. Barruet, F. Peiretti, O. Hadadeh, I. Juhan-vague, M.-C. Alessi, B. Binetruy. D027 Role de la voie de transduction P38MAPK (mitogen-activated protein kinase) dans les differenciations endotheliales et myogeniques des cellules souches embryonnaires. Archives of Cardiovascular Diseases. 2009 Mar 1; 102:s46.
      View in: Publisher Site
    17. O. Hadadeh, E. Barruet, F. Peiretti, M. Verdier, I. Juhan-vague, M.-C. Alessi, B. Binetruy. D028 L’expression des gènes PAI-1, tPA et uPA est fortement régulée pendant la différenciation des cellules souches embryonnaires en myocytes et adipocytes. Archives of Cardiovascular Diseases. 2009 Mar 1; 102:s46-s47.
      View in: Publisher Site